Centre Léon-Bérard
Records under this name other than the patents Centre Léon-Bérard holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 9 patents it holds.
Showing 1 to 9 of 9 · Back to Centre Léon-Bérard
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,130,817 | CD73 Blocking Agents now held by Innate Pharma In force · High confidence | In force | High confidence | |
| US 12,433,838 | Liposomal Formulation of Bacterial Lipopolysaccharide Combined with a Cytotoxic Agent, and Use Thereof in Anti-Tumour Therapy now held by Institut National de la Sante et de la Recherche Medicale (Inserm), Centre National de la Recherche Scientifique (CNRS), Universite Claude Bernard Lyon 1, Hospices Civils de Lyon and Centre Leon Berard In force · High confidence | In force | High confidence | |
| US 12,440,185 | Method for Determining a Mechanical Property of a Layered Soft Material now held by Institut National de la Sante et de la Recherche Medicale (Inserm), Université Claude Bernard Lyon 1 and Centre Leon-Berard In force · High confidence | In force | High confidence | |
| US 11,544,851 | Systems and Methods for Mesothelioma Feature Detection and Enhanced Prognosis or Response to Treatment now held by Centre Leon Berard In force · High confidence | In force | High confidence | |
| 15/537,263 | Genomic Classifier That Predicts Response to Multi-Kinase Inhibitor Treatment Introduction Abandoned Abandoned Jan 2, 2019 | Abandoned | Abandoned Jan 2, 2019 | |
| 16/090,006 | Lymphocytes Expressing CD73 in Cancerous Patient Dictates Therapy Abandoned Abandoned Mar 27, 2021 | Abandoned | Abandoned Mar 27, 2021 | |
| 16/348,775 | TLR3 Agonist for Use for Inducing Apoptosis in Senescent Cancer Cells held by Centre Léon-Bérard, Institut National de la Sante et de la Recherche Medicale (Inserm), Centre National de la Recherche Scientifique, Université Claude Bernard Lyon 1 and Hospices Civils de Lyon Abandoned Abandoned Jan 7, 2021 | Abandoned | Abandoned Jan 7, 2021 | |
| 18/886,180 | Combined Treatment with NETRIN-1 Interfering Drug and Immune Checkpoint Inhibitors Drugs Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 19/342,962 | Liposomal Formulation and Use in a Combination Product as an Anti-Tumour Therapy Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. |